avilexpharma.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
User-agent: * Disallow: /wp-admin/ Allow: /wp-admin/admin-ajax.php Sitemap:
Meta Tags
Title Avilex
Description The News Pipeline Company Science Contact Developing best in class neuroprotectants Avilex Pharma are developing best in class neuroprotectants, exploring an
Keywords N/A
Server Information
WebSite avilexpharma faviconavilexpharma.com
Host IP 93.191.158.41
Location Denmark
Related Websites
Site Rank
More to Explore
cloudsmartstore.com
dargroup.biz
fileformat.app
foundationprogram.online
hotrodsanctuary.com
installapkapps.com
latinbulletin.com
pkjobsin.com
surfans.net
goodthink.com
smardy-project.eu
abovetherestchimney.com
allchimneycleaningmichigan.com
arsiem.com
sdchimneysweeps.com
towelchic.com
wozaglobal.com
reserveasuite.com
yourtechnoland.com
thedynasty.mobi
avilexpharma.com Valuation
US$6,973,088
Last updated: 2023-05-17 00:55:43

avilexpharma.com has Semrush global rank of 1,517,879. avilexpharma.com has an estimated worth of US$ 6,973,088, based on its estimated Ads revenue. avilexpharma.com receives approximately 804,588 unique visitors each day. Its web server is located in Denmark, with IP address 93.191.158.41. According to SiteAdvisor, avilexpharma.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$6,973,088
Daily Ads Revenue US$6,437
Monthly Ads Revenue US$193,101
Yearly Ads Revenue US$2,317,211
Daily Unique Visitors 53,640
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
avilexpharma.com. A 60 IP: 93.191.158.41
avilexpharma.com. NS 3600 NS Record: ns3.dandomain.dk.
avilexpharma.com. NS 3600 NS Record: ns2.dandomain.dk.
avilexpharma.com. NS 3600 NS Record: ns.dandomain.dk.
avilexpharma.com. MX 3600 MX Record: 10 mx.spamfilter.io.
avilexpharma.com. TXT 3600 TXT Record: v=spf1 include:spf.dandomain.dk -all
HtmlToTextCheckTime:2023-05-17 00:55:43
News Pipeline Company Science Contact Developing best in class neuroprotectants Avilex Pharma are developing best in class neuroprotectants, exploring an exciting and promising drug target in the brain. Successfully completes phase 1 clinical trial Avilex Pharma successfully completes its phase 1 clinical trial of AVLX-144 - a potentially game-changing treatment for acute neurological… The treatment AVLX-144 Avilex Pharma is a clinical stage company developing best in class neuroprotectants Avilex Pharma is developing AVLX-144, a PSD-95 inhibitor and best-in-class neuroprotectant to treat patients suffering from acute conditions such as subarachnoid hemorrhage and acute ischemic stroke. Avilex Pharma is also developing a pipeline of neuroprotectants for multiple Indications. Inhibition of PSD-95 has been clinically validated and AVLX-144 provides a unique opportunity for orphan and broad indications Learn more Current Status Acute ischemic stroke 4 Every 4 minutes, someone dies of
HTTP Headers
HTTP/1.1 301 Moved Permanently
Connection: Keep-Alive
Date: Fri, 25 Feb 2022 09:08:17 GMT
Server: LiteSpeed
Location: https://avilexpharma.com/
X-NF-Server: Yes

HTTP/2 301 
set-cookie: uncode_privacy[consent_types]=%5B%5D; expires=Sat, 25-Feb-2023 09:08:17 GMT; Max-Age=31536000; path=/; secure
content-type: text/html; charset=UTF-8
x-redirect-by: WordPress
location: https://www.avilexpharma.com/
date: Fri, 25 Feb 2022 09:08:18 GMT
server: LiteSpeed
x-nf-server: Yes
alt-svc: quic=":443"; ma=2592000; v="43,46", h3-Q043=":443"; ma=2592000, h3-Q046=":443"; ma=2592000, h3-Q050=":443"; ma=2592000, h3-25=":443"; ma=2592000, h3-27=":443"; ma=2592000

HTTP/2 200 
set-cookie: uncode_privacy[consent_types]=%5B%5D; expires=Sat, 25-Feb-2023 09:08:18 GMT; Max-Age=31536000; path=/; secure
content-type: text/html; charset=UTF-8
link: ; rel="https://api.w.org/"
link: ; rel="alternate"; type="application/json"
link: ; rel=shortlink
date: Fri, 25 Feb 2022 09:08:18 GMT
server: LiteSpeed
x-nf-server: Yes
alt-svc: quic=":443"; ma=2592000; v="43,46", h3-Q043=":443"; ma=2592000, h3-Q046=":443"; ma=2592000, h3-Q050=":443"; ma=2592000, h3-25=":443"; ma=2592000, h3-27=":443"; ma=2592000
avilexpharma.com Whois Information
Domain Name: AVILEXPHARMA.COM
Registry Domain ID: 1756333483_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.rrpproxy.net
Registrar URL: http://www.key-systems.net
Updated Date: 2021-10-04T09:36:36Z
Creation Date: 2012-11-01T15:12:44Z
Registry Expiry Date: 2023-11-01T15:12:44Z
Registrar: Key-Systems GmbH
Registrar IANA ID: 269
Registrar Abuse Contact Email: abuse@key-systems.net
Registrar Abuse Contact Phone: +49.68949396850
Domain Status: ok https://icann.org/epp#ok
Name Server: NS.DANDOMAIN.DK
Name Server: NS2.DANDOMAIN.DK
DNSSEC: unsigned
>>> Last update of whois database: 2022-02-25T09:53:18Z <<<